| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/09/2004 | EP1424894A2 Inhibition of pathological angiogenesis in vivo |
| 06/09/2004 | EP1263449A4 Induction of beta cell differentiation in human cells by stimulation of the glp-1 receptor |
| 06/09/2004 | EP0941737B1 Apoptosis inducers |
| 06/09/2004 | EP0753053B1 ALPHAVIRUS cDNA VECTORS |
| 06/09/2004 | EP0681608B1 Therapeutic applications of chimeric organogenesis |
| 06/09/2004 | EP0547164B1 Methods for the diagnosis and treatment of diabetes |
| 06/09/2004 | CN1503678A Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases |
| 06/09/2004 | CN1503632A Nutritional composition for immune condition |
| 06/09/2004 | CN1503628A Use of cell penetrating peptides to generate antitumor immunity |
| 06/09/2004 | CN1502361A Medicine for treating chronic layngopharyngitis and preparation process thereof |
| 06/09/2004 | CN1502344A Multi-function medicine for beautifying and treating scald by boiled water and fire and cold injury, and special container |
| 06/09/2004 | CN1502324A Definition for synergic reverse promotion and oral cavity unbalance |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/09/2004 | CN1152881C New indolocarbazole alkaloids from marine actinomycete, its composition and use |
| 06/09/2004 | CN1152713C Dried blood factor composition comprising trehalose |
| 06/09/2004 | CN1152707C Medicine for curing chronic diarrhea |
| 06/09/2004 | CN1152703C Medicinal composition for treating skin itchings |
| 06/09/2004 | CN1152701C Kidney-benefiting and tranquilizing medicine and its prepn |
| 06/09/2004 | CN1152699C Medicine for treating and preventing senile dementia |
| 06/09/2004 | CN1152695C Medical wine for replenishing vital essence and invigorating vital function and its preparing process |
| 06/09/2004 | CN1152692C Silkworm excrement extracting process, extract and its use |
| 06/09/2004 | CN1152678C Pharmaceutical composition comprising lactobacillus plantarum and arginine |
| 06/08/2004 | US6747036 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia |
| 06/08/2004 | US6747010 NKT cell-activating agents containing α-glycosylceramides |
| 06/08/2004 | US6747004 Contacting embryonic forebrain cells in vitro with amount of endometrial bleeding associated factor protein having specified amino acid sequence effective to induce proliferation of forebrain cells |
| 06/08/2004 | US6746672 Isolated bifidobacteria that produce siderophores which inhibit growth of lactococcus lactis |
| 06/08/2004 | US6746671 Use of a cytokine-producing lactococcus strain to treat colitis |
| 06/08/2004 | US6746670 Regulatory T cells; methods |
| 06/08/2004 | US6746607 Polysaccharide matrix whereon is grafted a polymer coupled with an affinity ligand |
| 06/03/2004 | WO2004046348A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 06/03/2004 | WO2004046346A2 Self-containing lactobacillus strain |
| 06/03/2004 | WO2004046319A2 Bacteriophage having modified holin and uses thereof |
| 06/03/2004 | WO2004046310A2 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 06/03/2004 | WO2004045645A2 A bacteriophage preparation of enhanced stability by application of a block copolymer of ethylene oxide and propylene oxide |
| 06/03/2004 | WO2004045630A1 An application of bacteriophages in transplantation |
| 06/03/2004 | WO2004045563A2 Method of treatment of myocardial infarction |
| 06/03/2004 | WO2004045550A2 Immunization with porphyromonas gingivalis protects against heart disease |
| 06/03/2004 | WO2004045493A2 Methods of inducing or enhancing cartilage repair |
| 06/03/2004 | WO2004045490A2 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof |
| 06/03/2004 | WO2004027033A3 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/03/2004 | WO2004025416A3 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 06/03/2004 | WO2004024904A3 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/03/2004 | WO2004024198A8 Activator for forming platelet gel, platelet poor plasma gel or platelet rich plasma gel |
| 06/03/2004 | WO2004022031A3 Stable probiotic microsphere compositions and their methods of preparation |
| 06/03/2004 | WO2004011488A9 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
| 06/03/2004 | WO2003106974A3 Diagnosis and treatment of chemoresistant tumors |
| 06/03/2004 | WO2003103611A3 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 06/03/2004 | WO2003100024A3 Treatment for diabetes |
| 06/03/2004 | WO2003092604A3 Vascularization enhanced graft constructs |
| 06/03/2004 | WO2003089619A3 Placental derived stem cells and uses thereof |
| 06/03/2004 | WO2003004039A3 Composition comprising soy and use thereof in the prevention and/or treatment of various diseases |
| 06/03/2004 | WO2002102846B1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/03/2004 | WO2002073188A9 Method for generating replacement cells and/or tissues |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040107130 Physiological gastric bypass by appetite suppression |
| 06/03/2004 | US20040106896 System and method for forming a non-ablative cardiac conduction block |
| 06/03/2004 | US20040106864 Method of predicting stroke evolution utilising mri |
| 06/03/2004 | US20040106780 Preparing antibody isolated from blood for treatment of thrombocytopenia, tetanus, rubella and viral diseases |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106564 Use of slpi for treating chronic inflammatory intestinal diseases |
| 06/03/2004 | US20040106556 solvent extraction; amyloid precursor proteins |
| 06/03/2004 | US20040106555 Neurogenin3 and production of pancreatic islet cells |
| 06/03/2004 | US20040106541 Protein complex from ion-exchange chromatography for treatment of bacterial infections |
| 06/03/2004 | US20040106197 Central nerve system precursor cells inducing synaptogenic neurons in spinal cord |
| 06/03/2004 | US20040106196 Systems and methods for treating patients with processed lipoaspirate cells |
| 06/03/2004 | US20040106195 Method for identification of cell growth or differentiation factors |
| 06/03/2004 | US20040106185 Oral bacteriotherapy compositions and methods |
| 06/03/2004 | US20040106171 Peptides with anti-hypertensive properties |
| 06/03/2004 | US20040106159 Using protein fragments to induce cytokine response in CD8 and/or CD4 lymphocytes; screening mammals for previous exposure to antigens |
| 06/03/2004 | US20040106105 Vaccine |
| 06/03/2004 | US20040106094 Red blood cell composition |
| 06/03/2004 | US20040106093 Transgenic erythrocytes for use as tools in identifying modulators of cell proliferation |
| 06/03/2004 | US20040105914 Health foods containing natto kinase and fermented milk products |
| 06/03/2004 | US20040105893 256 Daltons compound, non proteinesious in nature,with an Ultraviolet spectra in methanol as a solvent produces a sharp peak at 225.4 nm |
| 06/03/2004 | US20040105892 body of a rattlesnake in the crotalus durissus family is continuously baked until the body completely dehydrates and pulverizing the dehydrated midsection of the body into a fine granular powder |
| 06/03/2004 | US20040105867 Prevention of autoimmune disease in mammals |
| 06/03/2004 | US20040105864 Food supplement |
| 06/03/2004 | US20040105849 spinal muscular atrophy diseases for genetic disorders treatment with vitamin c and pectins, flavonoids, enzyme supplements or enteric bacterium |
| 06/03/2004 | US20040105848 Enteric dialysis to treat renal, kidney and gastrointestinal problems andprobiotic bacteria to reduce urea |
| 06/03/2004 | US20040105847 Promoting Recovery from Damage to the Central Nervous System |
| 06/03/2004 | CA2506050A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 06/03/2004 | CA2506031A1 Self-containing lactobacillus strain comprising a thya mutation and therapeutic applications thereof |
| 06/03/2004 | CA2504331A1 Bacteriophage having modified holin and uses thereof |
| 06/02/2004 | EP1424394A2 TAT transdominant variants from HIV virus |
| 06/02/2004 | EP1424387A1 Method of extended culture for antigen-specific cytotoxic t lymphocytes |
| 06/02/2004 | EP1424344A1 Modified cDNA factor VIII and its derivates |
| 06/02/2004 | EP1424082A1 Method of regenerating bone/chondral tissues by transferring transcriptional factor gene |
| 06/02/2004 | EP1424075A2 Acid and bile-resistant lactobacillus isolates having the ability to lower and addimilate cholesterol |
| 06/02/2004 | EP1424074A1 Nutritional compositions for controlling blood glucose level |
| 06/02/2004 | EP1423509A2 Differentiation of neural stem cells and therapeutic use thereof |
| 06/02/2004 | EP1423504A2 Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof |
| 06/02/2004 | EP1423503A2 Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd |
| 06/02/2004 | EP1423176A2 Method and apparatus for removal of insulin binding proteins (ibp) from biological fluids |
| 06/02/2004 | EP1423134A2 Human secreted proteins |
| 06/02/2004 | EP1423126A2 Treatment of hyperproliferative conditions of body surfaces |
| 06/02/2004 | EP1423095A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/02/2004 | EP1423082A2 Plasma protein matrices and methods for their preparation |
| 06/02/2004 | EP1423012A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 06/02/2004 | EP1330514B1 Ex vivo oxidatively stressed cll cells in chronic lymphocytic leukemia (cll) treatment |
| 06/02/2004 | EP1227824B1 Transplant/implant device and method for its production |